https://purisys.com/botanix-announces-cannabidiol-supply-agreement-with-purisys/ 2023-08-08T20:13:33+00:00 monthly 0.2 https://purisys.com/purisys-cannabinoid-ingredients-descheduled-by-u-s-drug-enforcement-agency/ 2023-08-08T20:10:55+00:00 monthly 0.2 https://purisys.com/gb-sciences-and-purisys-announce-preferred-supplier-relationship-to-advance-cannabinoid-containing-pharmaceuticals/ 2023-08-08T20:10:10+00:00 monthly 0.2 https://purisys.com/purisys-adds-iso-certifications-confirming-its-commitment-to-quality-and-excellence/ 2025-02-10T21:44:36+00:00 monthly 0.2 https://purisys.com/understanding-the-fda-process-to-commercialize-drugs/ 2023-08-08T19:19:24+00:00 monthly 0.2 https://purisys.com/navigating-the-complexities-of-controlled-substances/ 2024-10-29T18:46:15+00:00 monthly 0.2 https://purisys.com/working-with-an-experienced-team-can-maximize-your-roi/ 2023-08-08T19:19:23+00:00 monthly 0.2 https://purisys.com/what-to-consider-when-selecting-a-cdmo-for-api-manufacturing/ 2023-08-08T19:19:22+00:00 monthly 0.2 https://purisys.com/noramco-announces-the-acquisition-of-the-cambrex-drug-product-business-unit/ 2023-11-17T15:43:46+00:00 monthly 0.2 https://purisys.com/noramco-announces-strategic-alignment-with-purisys-and-halo-pharma/ 2024-07-19T19:15:52+00:00 monthly 0.2 https://purisys.com/purisys-activates-drug-master-file-for-nalmefene-introducing-new-solution-for-acute-opioid-overdose-treatment/ 2024-09-24T17:58:45+00:00 monthly 0.2 https://purisys.com/nitrosamine-testing-deadline-is-august-1-2025-are-you-ready/ 2025-07-07T13:13:35+00:00 monthly 0.2 https://purisys.com/noramco-ceo-lee-karras-discusses-25-million-halo-investment-with-pharmtech/ 2025-03-19T20:21:05+00:00 monthly 0.2 https://purisys.com/noramco-ceo-lee-karras-discusses-3-key-trends-impacting-the-cdmo-industry/ 2025-06-09T04:48:30+00:00 monthly 0.2 https://purisys.com/the-security-of-onshore-manufacturing/ 2025-07-07T13:29:18+00:00 monthly 0.2